Assessment of LBR-101 In Chronic Migraine

- Chronic Migraine
- Completed

Study Title: Assessment of LBR-101 In Chronic Migraine

Teva Identifier: LBR-101-021

ClinicalTrials.gov Identifier: NCT02021773

Study Status: Completed

Trial Condition(s): Chronic Migraine

Interventions: Biological: LBR-101 High Dose | Biological: LBR-101 Low Dose | Biological: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Click for participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age Range: 18 Years to 65 Years

Trial Duration: 01/01/2014 - 03/01/2015

Phase: Phase 2

Study Type

Interventional